Johnathan Xiande Lim

Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC

Joe Yeong, Tira J. Tan, Zi Long Chow et al. · Journal of Clinical Pathology · 2020 · 74 citations · Full text

Medicine, Oncology, Immunotherapy +13

Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers

Dominique Yuan Bin Seow, Joe Yeong, Johnathan Xiande Lim et al. · Breast Cancer Research and Treatment · 2020 · 56 citations

Medicine, Cancer Biology, Oncology +13

Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer

Dong Yeul Lee, Bernett Lee, Huihua Li et al. · Breast Cancer Research · 2022 · 56 citations · Full text

Medicine, Oncology, Pathology +17

Soft Tissue Leiomyosarcoma With Microsatellite Instability, High Tumor Mutational Burden, and Programmed Death Ligand-1 Expression Showing Pathologic Complete Response to Pembrolizumab: A Case Report

Timothy Kwang Yong Tay, Joe Yeong, Eileen Xueqin Chen et al. · JCO Precision Oncology · 2022 · 14 citations · Full text

Medicine, Oncology, Pathology +17

Characteristics, behaviour and role of biomarkers in metastatic triple-negative breast cancer

Yutaro Goto, Aye Aye Thike, Clara Chong Hui Ong et al. · Journal of Clinical Pathology · 2019 · 11 citations

Medicine, Oncology, Pathology +16